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A new technique for treating skinned cardiac muscle fibers has been developed in which troponin I IS extracted, giving rise to unregulated fibers. 
The effect of the 12-residue troponin I peptide on these fibers indicates that this region of troponin I is solely responsible for muscle relaxation 
(inhibition of force). Furthermore, troponin I peptide-tropomn C reconstituted fibers are stable through several contraction-relaxation cycles 
indicating the peptide can switch binding sites between actm and tropomn C. The troponin I peptide can substitute for the native protein as part 
of the calcmm-sensitive molecular switch that controls muscle regulatton. 
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1. INTRODUCTION 
The role of troponin I (TnI) as an inhibitor of the 
contractile ATPase in muscle is now well established 
(for review see [I]). It has been previously demonstrated 
that a 12-residue synthetic peptide of troponin I, TnI 
peptide 104-I 15 (Ac-G-K-F-K-R-P-P-L-R-R-V-R- 
amide), is able to substitute for its native protein (which 
is 15-fold larger) in the inhibition of the acto-Sl-TM 
ATPase activity by binding to acin-tropomyosin [2,3]. 
In addition, this inhibitory peptide has been shown to 
bind to troponin C (TnC) in the presence of Ca” [4-lo] 
which releases TnI peptide inhibition [7]. These results 
lead us to propose that this region of TnI switches be- 
tween binding sites on actin and TnC in a Ca”-depend- 
ent manner. This hypothesis is based on biochemical 
studies done in solution using purified proteins. It has 
also been shown that the TnI peptide inhibits force 
development in skinned striated muscle fibers, at sub- 
maximal Ca’+ activation [IO,1 I]. Skinned fibers are 
muscle fibers in which the cell membrane has been per- 
meabilized and hence represents a structurally intact 
system. These fibers respond to changes in the Ca” 
concentration in much the same way as living muscle, 
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contracting at high concentrations of Ca2’ and relaxing 
at low levels. These results are complicated to interpret 
because the peptide competes with the native TnI pres- 
ent in the fiber for its binding site on TnC and/or on 
actin thereby directly inhibiting the actin-myosin inter- 
action. By utilizing a new method of treating skinned 
cardiac muscle fibers with vanadate which permits the 
reversible extraction of TnI as well as some TnC and 
TnT [12,13], we now have obtained evidence for the 
direct interaction of TnI peptides with actin and a Ca2’- 
dependent interaction with TnC. The TnI-depleted fi- 
bers have enabled us to further investigate the ability of 
the TnI peptide to substitute for TnI as part of the 
regulatory switch which controls muscle contraction. 
2. MATERIALS AND METHODS 
2.1. Preparation of peptide and protein 
The peptides were synthesrzed by standard solid-phase peptide syn- 
thesis procedures. The protems, TnT and TnC were purified from 
whole Tn. The peptides and proteins were purified by reversed-phase 
HPLC [6.14]. For the skinned fiber assays. the peptides were dissolved 
in 20 mM imidazole, pH 6.7. TnT was dissolved and dialyzed against 
60 mM tmidazole, 20 mM ATP, 20 mM creatine phosphate, 10 mM 
MaN,. IO mM EGTA, 25 mM MgCl,, pH 6.7 (double concentrated 
relaxing solution). To ensure TnC was Ca”-free. it was dissolved in 
20 mM imidazole, 2 mM EDTA, 6 M guanidine-HCl, 1 mM DTT, 
then dialyzed extensively against 20 mM imidazole, pH 6.7. The con- 
centrations of peptide stock solutions were determined by amino acid 
analysis and protein solutions by the Bradford assay. 
2.2. Tnl-depleted cardiac skinned muscle$bers 
Porcine skinned cardiac fibers were mounted with fast-setting glue 
on an isometrtc force transducer (AME 80, SensoNor, Horten, Nor- 
way) and a glass rod attached to a micromanipulator [15]. When 
monitoring simultaneous changes m the ATPase activity and force the 
method described by Gtith and Wojciechowski [16] and Strauss et al. 
[13] was used. Danz-labelled skeletal TnC was obtained from Dr. J. 
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Potter, University of Miami. Changes in fluorescence of Danz-labelled 
TnC was monitored as described by Giith and Potter [17]. The porcine 
skinned cardiac fibers were relaxed by immersion mto relaxing solu- 
tion (30 mM imidazole, 10 mM ATP, 10 mM creatine phosphate, S 
mM NaN,, 5 mM EGTA, 12.5 mM MgC& and 380 Uml’ creatme 
kinase. pH 6.7. ionic strength 100 mM). The contracting solution was 
analogous to the relaxing solution except EGTA was replaced by a 
Ca*‘-EGTA buffer to give a pCa of 4.5 (5 mM CaCl& The concentra- 
tion of Ca” in the buffers was determined from the ratio of EGTA 
to Ca”-EGTA, essentially accordmg to Fabiato and Fabiato [18], 
except that the apparent dissociation constant of 1.6 PM for Ca2+- 
EGTA buffer at pH 6.7 and 20°C was used [19]. After contraction, 
the fibers were incubated in 10 mM vanadate (Na,VO,) in relaxing 
solution for 10 min [12,13]. The vanadate mhibited force. Vanadate 
was washed from the fibers using relaxing solution until maximum 
force was achieved. The fibers were tested for Ca”-insensitivity by 
transferring between fresh relaxing, contracting and relaxmg solu- 
tions. Only the fibers which displayed no increase in force m the 
presence of Ca” were used in these experiments. 
2.3. Reconstirution of Tnl-depleted fibers 
Vanadate-treated fibers were incubated at relaxmg solution con- 
taining TnI peptide until maximum inhibition occurred (30-45 mm). 
The TnI peptide-loaded fibers were tested for the absence of Ca” 
sensitivity (as above). The fibers were then incubated in relaxing solu- 
tion containing TnC (20-30 mm). Excess (unbound) TnC was washed 
from the fiber by immersion in relaxing solution. Incubation of the 
vanadate-treated fibers with 30 PM TnT (15-30 min) subsequent to 
the TnI peptide-TnC reconstitution does not overly change the Cal’- 
dependent characteristics of the fibers (Fig. 4). however, it did increase 
the consistency of the reconstituted fibers displaying full Ca*+-sensitiv- 
ity (contraction followed by relaxation). Therefore, an initial TnT 
incubation has now been adopted as the standard reconstitution pro- 
tocol. 
2.4. SDS-gel electrophoresis 
Protein samples and Individual fibers were homogemzed in a SDS 
(2%) urea (6 M) sample buffer. The proteins were separated by SDS- 
PAGE (15% acrylamide-0.4% bis-acrylamide) on duplicate gels [13]. 
One gel was stained for total protein content using Coomassie blue, 
while the other was electroblotted to nitrocellulose for immunoanaly- 
sis. This blot was probed for TnI content with a monoclonal TnI 
antibody obtained from Dr. Dhoots, University of London, and 
horseradish peroxidase-labelled secondary antibody (Jackson Immu- 
nolab, Dianova GmbH). Under these conditions, TnC is not clearly 
resolved from LC2. 
3. RESULTS AND DISCUSSION 
We have confirmed that extraction of TnI and partial 
extraction of TnC and troponin T (TnT) from the car- 
diac skinned fibers (cross-striated muscle) occur after 
treatment with 10 mM vanadate [ 12,131, giving rise to 
unregulated fibers. Fig. 1 shows SDS-PAGE gels and 
the corresponding immunoblot using an antibody 
against Tnl for a control fiber (a fiber not treated with 
vanadate), a vanadate-treated TnI-depleted fiber, and 
vanadate-treated fiber reconstituted with skeletal TnT, 
TnI peptide, and skeletal TnC. It is clear from the im- 
munoblot that there is no significant amount of TnI 
remaining in the vanadate-treated fibers compared to 
the control fiber. SDS gel electrophoresis showed that 
the vanadate-treated fibers contain substantial quanti- 
ties of endogenous TM and TnT ([ 131 and Fig. 1). How- 
ever, exogenously supplied TnT is required for consis- 
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Fig. 1. SDS-gel electrophoresis (upper panel) and corresponding im- 
munoblot (lower panel) of: troponin (lane A), bovine TnI (lane B), a 
control skinned porcine cardiac fiber (lane C), a vanadate-treated fiber 
(lane D), and a vanadate-treated porcine skinned fiber reconstituted 
with skeletal TnT, TnI peptide and skeletal TnC (lane E). The cardiac 
TnT endogenous to the fiber (labelled p-TnT) has a different mobility 
on the gel than the exogenously supplied skeletal TnT (labelled b- 
TnT). The peptide-reconstituted fiber (lane E) contained no TnI and 
was comparable to the vanadate-treated unregulated fiber (lane D). 
tent and functional TnI peptide-TnC reconstitution 
indicating some TnT may be extracted during vanadate- 
treatment (discussed later). Since TnC does not stain 
well by Coomassie blue and migrates very near a light 
chain of myosin (LC,), it is difficult to determine the 
amount of TnC retained in the vanadate-treated fibers. 
However, because incubation with TnC restores full 
Ca’+ sensitivity of TnI reconstituted fibers [ 131 and TnI 
peptide reconstituted fibers (Fig. 3), it may be con- 
cluded that a significant amount of TnC has been ex- 
tracted. 
Incubation with 10 mM vanadate relaxed the fibers 
completely but after transfer to relaxing solution (pCa 
8.0) without vanadate, force slowly developed despite 
the continued absence of Ca2’ [12,13]. In fact, after 
removal of the vanadate. the skinned muscle fibers 
(TnI-depleted fibers) develop near maximum force 
which is similar to the force induced by Ca’+ (pCa 
- 4.5) in the fibers prior to vanadate-treatment. How- 
ever, the vanadate-treated fibers, unlike the non-ex- 
tracted fibers, remain contracted regardless of the Ca” 
concentration. i.e. the vanadate-treated fibres are Ca’+- 
insensitive. Using these unregulated fibers we have de- 
termined the effects of the TnI inhibitory peptide on the 
contractile behavior of functionally unregulated muscle 
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Fig. 2. Dose dependence of the skeletal TnI peptide Inhibition of the 
vanadate-treated TnI-depleted tlbers. The relative force obtained at 
each concentration of peptide was taken as a fraction of the force 
elicited in relaxing solution after vanadate-treatment and washout of 
the vanadate (mean f S.D. of 4 experiments). Following vanadate 
treatment and wash out of the vanadate with relaxing solution, the 
fibers were incubated with increasing quantities of the TnI peptide (0) 
in relaxing solution. 
and determined the ability of the peptide to function as 
part of the regulatory switch. 
The addition of the skeletal TnI peptide 104115 to 
the TnI-depleted fibres inhibits the Ca2’-insensitive 
force in a dose-dependent manner (Fig. 2). Maximum 
inhibition of 67% If: 2.8 (n = 9) occurs at a concentra- 
tion of TnI peptide of approximately 100 yM. This is 
similar to the degree of inhibition obtained when the 
TnI protein is incorporated into the vanadate-treated 
fibers [13]. Neither the TnI peptide or protein can to- 
tally inhibit the Ca2’-insensitive force. The inhibition by 
the TnI peptide may be specifically attributed to the 
structure of the peptide rather than to its net charge (6 
positive charges), since a scrambled peptide in which the 
amino acid sequence has been altered (Ac-R-F-R-V-K- 
L-R-P-R-G-K-P-amide) was less effective than the na- 
tive peptide. At 50 PM, the native TnI peptide induces 
a significant loss of force (65% in 10 min) while the 
scrambled peptide at the same concentration induced 
only a very small loss of force (10% in 10 min) (data not 
shown). In addition, single glycine analogs of the TnI 
peptide are much less potent than the native peptide in 
binding TnC and inhibiting the acto-S 1 ATPase activity 
[5]. These results indicate that any change to the amino 
acid sequence of the native peptide reduces the biologi- 
cal activity. 
The vanadate-treated fibers which were relaxed by 
the native TnI peptide (peptide-loaded fibers) developed 
little or no force upon addition of calcium, i.e. the pep- 
tide-loaded fibres demonstrated essentially no Ca2’ sen- 
sitivity. In fact, given sufficient time, the peptide could 
be washed from the vanadate-treated fibres in either the 
presence or absence of Ca2’ (data not shown). Washout 
of the peptide was monitored by the return of high level 
of force in the fiber that was Ca2’-independent. This 
indicates that there is reversible binding of the peptide 
to the vanadate-treated fibers and that the TnI peptide 
by itself is not sufficient for imparting Ca2’ dependence 
of contraction of the muscle fiber. 
After incorporation of skeletal or cardiac TnC into 
the peptide-loaded fibers, calcium-dependent force was 
restored (Fig. 3A). In fact, the reconstituted fibres (skel- 
etal TnI peptide and TnC) were stable through several 
contraction-relaxation cycles. The Ca2’-induced con- 
traction of the reconstituted fiber was accompanied by 
a corresponding increase in the ATPase activity and the 
Ca”-dependent conformational changed in TnC as 
monitored by the qualitative change in the fluorescence 
of the Danz-labelled TnC (Fig. 3B). These results sug- 
gest that the TnI peptide is able to switch between its 
binding site on TnC and actin-TM depending on the 
concentration of Ca”. It is important to note that the 
contraction cycles of the peptide-TnC reconstituted 
A 1 TnllOL115 150~M /TnC YOvM 
0 2 L 6 8 IO 
minutes 
.I 
Fig. 3. Force tracing of the reconstitution of the peptide-TnC fiber 
and return of the Ca*’ sensitivity (panel A). The TnI-depleted fibres 
followmg vanadate treatment and washout (fully contracted) were 
incubated in relaxing solution containing 150pM skeletal TnI peptide 
until maximum inhibition (> 90% in this experiment) occurred in 
approximately 30 min. The TnI peptide-loaded fibers where then incu- 
bated in relaxing solution containmg 90 PM bovine cardiac TnC for 
30 mm. Panel B shows the qualitative changes in the fluorescence of 
a fiber reconstituted with peptide and Danz labelled skeletal TnC 
(dotted line) and simultaneous changes m the ATPase activity (0) and 
force (solid line) of a fiber reconstituted with peptide and skeletal 
TnC in the absence and presence of Ca”. 
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Fig. 4. pCa-force relationship of cardiac skinned fibers before vanadate treatment and following vanadate treatment and reconstitution with either 
TnI peptide and skeletal TnC or the combmation of TnI peptide and skeletal TnC and skeletal TnT. Panel A shows the control fibers (closed circles) 
and the TnI peptide-TnC reconstituted fibers (open circles, n = 7); panel B shows the control fiber (open squares) and the TnI peptide-TnC-TnT 
reconstituted fibers (closed squares, II = 5)). The error bars Indicate the mean f S.D. Concentration of peptide was 143 PM, TnC 100 ,uM and 
skeletal TnT if present was 30 ,LLM. The vanadate-treated fibers were incubated in TnT or TnC for 20 min and mcubated with the pepttde until 
maximum Inhibition of force had occurred (approximately 30-50 mm). 
fiber were done in relaxing and contracting solutions The ability of the TnI peptide to substitute for TnI is 
that contained neither TnI peptide nor TnC. During further demonstrated by the similar relationship be- 
incubation with TnC, there is a small increase in force tween Ca’+ and force development of the reconstituted 
because of washout of the peptide (probably due to fibres (skeletal TnI peptide plus TnC) compared to the 
competition between TnC and actin for the peptide). control fibres containing endogenous Tn (Fig. 4A). The 
Once in relaxing solution the reconstituted fibers (pep- pCa,, values for the control and reconstituted fibers 
tide plus TnC) were very stable and there was no wash- were 5.5 but there was a decrease (0.6) in the Hill coef- 
out of the peptide or TnC detected since there was no ficient from 2.5 to 1.9 for the control and reconstituted 
further increase in force with time in Ca2+-free solu- fibers, respectively. If TnT was also incorporated into 
tions. However, with increases in Ca’+, the reconstituted the vanadate-treated fibers along with the TnI peptide 
fibers generated force. Essentially. the Ca2’-dependent and TnC (Fig. 4B), the effect on the Cal+-force relation- 
regulation of contraction in the fibers were restored. ship was similar to the fibers which were reconstituted 
The maximum force developed upon addition of Ca’+ with only peptide and TnC. The pCa,, values for the 
was approximately 87% of the force exhibited by the control and reconstituted fibers with TnT were 5.6 and 
fiber following vanadate treatment. It should be noted there was a decrease (0.5) in the Hill coefficient from 1.9 
that several fibers exhibited 100% recovery of the max- to 1.4, respectively. Incubation of the vanadate-treated 
imum force. As seen from the SDS-gel and correspond- fibers with TnT subsequent to the TnC-peptide recon- 
ing TnI immunoblot (Fig. l), TnI is extracted from the stitution did not overly change this characteristic of the 
fiber upon vanadate treatment and is not present in the fibers. In solution studies, TnT is not required for TnC 
fibers reconstituted with the TnI peptide, TnT and TnC. (in the presence of Ca”) to release TnI or TnI peptide 
Therefore, the contraction and relaxation exhibited by inhibition of the acto-S 1 -tropomyosin ATPase activity 
the reconstituted fiber must be due to the replacement [7]. The advantage of incubating with TnT was that 
of TnI by the TnI peptide. It is apparent that the Tnl more of the reconstituted fibers displayed full Ca”+- 
peptide is able to replace TnI in regulating the cycling sensitivity (contraction followed by relaxation). Nine of 
of contraction and relaxation of the cardiac skinned the fourteen fibers reconstituted with TnI peptide-TnC 
muscle fiber. were able to produce repeated Ca”-dependent contrac- 
226 
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Relative Force 
Fig. 5. Tension cost of a skinned cardiac fiber (0) compared to fibers 
reconstituted with the TnI peptide and skeletal TnT and TnC (0). The 
Ca2’-dependent increase in force and ATPase of the skinned cardiac 
fiber prior to vanadate treatment and following reconstitution with 
TnI pepttde (143 PM) and TnT (130 PM) and TnC (100 PM) was 
determined at the pCa values of 8.0.6.0,5.6,5.2 and 4.3 (mean f S.D., 
n = 3). (a) denotes the force/ATPase relationship of the TnI-depleted 
fibers following vanadate treatment and washout. The basal ATPase 
activity in relaxing solution was subtracted from the values obtained 
at the various Ca” concentrations. 
tions compared to approximately eleven of the twelve 
fibers reconstituted with TnT, TnI peptide and TnC. 
The reconstituted fibers that did not display full Ca’+ 
sensitivity (fibers contracted but then did not relax) 
were not used. It must be noted that full Ca’+ sensitivity 
is consistently reconstituted by addition of only TnI and 
TnC [13]. These results suggest either TnT is not re- 
quired for Cal’-dependent contraction and relaxation 
of the muscle or that the amount of TnT extracted 
during vanadate treatment is variable. SDS gels of TnI 
peptide-TnC fibers (no TnT incubation) which display 
Ca*+ sensitivity, showed that there is still significant 
amounts of native TnT present (data not shown, [13]) 
while in the TnT-TnI peptide-TnC reconstituted fibers, 
there is excess TnT present (Fig. 1). It is possible that 
incubation with TnT followed by TnI peptide and TnC 
ensures that there is a full complement of ‘regulatory 
complexes’ in the fiber. TnT is not critical for TnI pro- 
tein reconstituted fibers [13] most likely because TnI has 
multiple sites of interaction with TnC, and some are 
insensitive to Ca**. Therefore, under relaxing or con- 
tracting conditions, TnC would be bound to the thin 
filament via TnI. On the other hand, in the peptide 
reconstituted fibers in the absence of Ca” (relaxation), 
the peptide is bound to actin-TM while TnC is an- 
chored to the thin filament only through its interaction 
with TnT. If TnT is not present, then TnC is dissociated 
from the filament and could be washed from the fiber. 
In order to keep TnC attached to the TnI peptide recon- 
stituted thin filament during relaxation, TnT is re- 
quired. 
The relationship between the ATPase activity and 
force of cardiac muscle during Ca*’ activation of the 
fibers prior to vanadate treatment (control) and after 
vanadate-treatment and addition of peptide was also 
determined (Fig. 5). The Ca*‘-dependent ATPase of the 
native control and reconstituted fibers (TnT-TnI pep- 
tide-TnC) consists of two components, a Ca*+-tension 
independent and tension dependent portion. The slope 
of the latter, the ‘isometric tension cost’ is identical in 
both the native and reconstituted fibers. This indicates 
that the ‘tension cost’ of the native and reconstituted 
fibers is similar, i.e. the same amount of energy (ATPase 
activity) is required to produce or maintain a certain 
amount of force for a given time. Since we assume the 
tension-dependent ATPase corresponds to the contrac- 
tile ATPase, then the slope of the force-ATPase rela- 
tionship may be taken as a reflection of the ‘tension 
cost’ and of the apparent crossbridge detachment rate 
constant ‘g’ [20]. The results suggest that the crossbridge 
detachment rate constant is similar in native skinned 
fibers and in skinned fibers reconstituted with the TnI 
peptide, TnT and TnC at different levels of Ca’+. 
4. CONCLUSION 
The results of this study have shown that the TnI 
peptide is able to functionally substitute for the whole 
TnI protein in imparting calcium regulation of contrac- 
tion in a semi-intact (skinned) cardiac muscle fiber. 
What makes this finding astonishing is that this 12- 
residue peptide can inhibit force development (relaxa- 
tion) by binding to actin (residues l-28) [21-231 and 
that in the presence of Ca*’ this inhibition is released by 
binding to TnC (contraction). We interpret this to mean 
that the TnI peptide must be switching binding sites 
from actin to TnC and vice versa depending on whether 
calcium is or is not present. Obviously, the peptide acts 
as a calcium-dependent molecular ‘switch’ and thus a 
true functional mimic of the TnI protein. 
Since the peptide induces relaxation of skinned mus- 
cle fiber, this region of TnI and its interaction with actin 
is solely responsible for the inhibition of force develop- 
ment, possibly by inhibiting the formation of strongly 
bound crossbridges. This indicates that the interactions 
of the N-terminus of actin (residues l-28), with myosin 
[23,24] must also be critically involved in both force 
generation and ATPase activity. 
To our knowledge, this is the first report of a syn- 
thetic peptide which, by changing binding sites from one 
protein to another, may function as a molecular switch 
in a reconstituted complex cellular system such as that 
involved in muscle regulation. Clearly, these studies 
support the use of synthetic peptides to unravel complex 
protein-protein interactions in biological systems. 
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